Browsing Category
Forex
Markets Flat Following Trump/Biden Dust-Up
U.S. stock markets are flat today as traders prepare for the weekend break. At the halfway point of the Wall Street session, the DJIA DOW (-64), S&P 500 SPX (-1), and…
Read More...
Read More...
XAU/USD buyers attack $1,970 to avoid monthly losses
Gold keeps Friday’s positive momentum to pierce $1,970.
Traders cheer US dollar weakness, ignore mixed updates on virus and vaccine.
American Congress…
Read More...
Read More...
EIA Reports 1 Million Barrel Draw On Supply
The weekly crude oil inventory cycle is complete and supplies continue to shrink. According to the U.S. Energy Information Administration (EIA), crude oil stocks-on-hand…
Read More...
Read More...
Fear will continue to be the main market motor
Here is what you need to know on Monday, November 2:
The greenback finished October with gains against most major rivals, backed by a sour market’s…
Read More...
Read More...
Go First cancels all flights till May 12 due to ‘operational reasons’
You have updates
21:58 IST, May 5th 2023…
Read More...
Read More...
All eyes on the US CPI data later today
Well, with markets now largely convinced that the Fed will head to the sidelines after last week's FOMC meeting decision, this will prove to be the first litmus test. You can…
Read More...
Read More...
Investors Check Risk To Open Weekly Wall Street Trade
It’s been a rough morning on Wall Street as stimulus hopes are quickly fading. Just over the halfway point of the U.S. session, the DJIA DOW (-833), S&P 500 SPX (-84), and…
Read More...
Read More...
Australian Dollar May Rise on RBA, Economic Outlook, Strong Risk Appetite
AUSTRALIAN DOLLAR FUNDAMENTAL OUTLOOK: BULLISHAustralian Dollar may rise on RBA rate decision and economic stabilizationResilient risk appetite, support from…
Read More...
Read More...
Forex Signals Brief for Oct 14: US PPI Ahead
US Market WrapUS markets will be looking out for the latest PPI print today as markets are likely coming to the realisation that there will be no stimulus in the US before the…
Read More...
Read More...
Lilly Reports First-Quarter 2023 Financial Results, Highlights Continued Core
Revenue in Q1 2023 decreased 11% driven by a $1.47 billion decline in revenue from COVID-19 antibodies. Excluding COVID-19 antibodies, revenue in Q1 2023 increased 10%, driven…
Read More...
Read More...